×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
18:00
Introduction
Dr Leïla Bengrine-Lefevre
18:05
Les nouvelles recommandations St-Paul-de-Vence appliquées en vraie vie:
  • Cas clinique d’une patiente en première ligne d’un cancer de l’ovaire avancé
    Dr Fernando Bazan
     
  • Cas Clinique d’une patiente en rechute d’un cancer de l’ovaire avancé
    Dr Leïla Bengrine-Lefevre
19:05
Défauts de la recombinaison homologue (HRD):  définition et perspectives thérapeutiques
Dr Elisabeth Luporsi
19:25
La chirurgie à l’ère des PARP Inhibiteurs
Pr Chérif Akladios
19:55 Conclusion

 

Shooting date : 2021-07-12
Last update : 2021-12-23
1 comment
Join the Discussion
  • mohamed S. merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, January 8th 2025 from 06:30pm to 07:45pm (GMT+1)
    Honolulu : Wednesday, January 8th 2025 from 06:30am to 07:45am (GMT+1)
    San Francisco : Wednesday, January 8th 2025 from 08:30am to 09:45am (GMT+1)
    New York : Wednesday, January 8th 2025 from 11:30am to 12:45pm (GMT+1)
    Buenos Aires : Wednesday, January 8th 2025 from 01:30pm to 02:45pm (GMT+1)
    London / Dublin : Wednesday, January 8th 2025 from 04:30pm to 05:45pm (GMT+1)
    Paris / Berlin : Wednesday, January 8th 2025 from 05:30pm to 06:45pm (GMT+1)
    Istanbul : Wednesday, January 8th 2025 from 06:30pm to 07:45pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 8th 2025 from 08:30pm to 09:45pm (GMT+1)
    Bangkok : Wednesday, January 8th 2025 from 11:30pm to 12:45am (GMT+1)
    Shanghai : Thursday, January 9th 2025 from 12:30am to 01:45am (GMT+1)
    Tokyo : Thursday, January 9th 2025 from 01:30am to 02:45am (GMT+1)
    Sydney : Thursday, January 9th 2025 from 02:30am to 03:45am (GMT+1)
    Wellington : Thursday, January 9th 2025 from 04:30am to 05:45am (GMT+1)

    Bénéfices de la maintenance par iPARP en 1L du cancer de l’ovaire

    Share
    Friday, March 21st 2025 from 02pm to 06:30pm (GMT+1)
    Honolulu : Friday, March 21st 2025 from 02am to 06:30am (GMT+1)
    San Francisco : Friday, March 21st 2025 from 04am to 08:30am (GMT+1)
    New York : Friday, March 21st 2025 from 07am to 11:30am (GMT+1)
    Buenos Aires : Friday, March 21st 2025 from 09am to 01:30pm (GMT+1)
    London / Dublin : Friday, March 21st 2025 from 12pm to 04:30pm (GMT+1)
    Paris / Berlin : Friday, March 21st 2025 from 01pm to 05:30pm (GMT+1)
    Istanbul : Friday, March 21st 2025 from 02pm to 06:30pm (GMT+1)
    Moscou / Dubaï : Friday, March 21st 2025 from 04pm to 08:30pm (GMT+1)
    Bangkok : Friday, March 21st 2025 from 07pm to 11:30pm (GMT+1)
    Shanghai : Friday, March 21st 2025 from 08pm to 12:30am (GMT+1)
    Tokyo : Friday, March 21st 2025 from 09pm to 01:30am (GMT+1)
    Sydney : Friday, March 21st 2025 from 10pm to 02:30am (GMT+1)
    Wellington : Saturday, March 22nd 2025 from 12am to 04:30am (GMT+1)

    Transpyrenean Oncogynae Symposium

    Advancing gynecologic oncology: from molecular insights to clinical practice

    Share
    Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
    New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

    Last improvements in advanced ovarian cancer treatment

    Trials that have or will impact practices in the management of patients with advanced ovarian cancer

    Share
    Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT+1)
    New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+1)

    Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

    Share
    Scroll Up